MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
CODX - Co-Diagnostics Inc
$8.51
-0.11(-1.28%)8:00:01 PM 10/21/2021
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

No summary
Related Topics
Peers

Related Peers

Stock news

    10/13/2021CODX
    Investing in Co-Diagnostics (NASDAQ:CODX) three years ago would have delivered you a 230% gain

    It might be of some concern to shareholders to see the Co-Diagnostics, Inc. ( NASDAQ:CODX ) share price down 19% in the...

    10/6/2021CODX
    Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test

    Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd ("CoSara," or the "JV"), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization ("CDSCO") in India to manufacture and sell its Saragene™ Dengue and Chikungunya Multiplex RT-PCR test as an in vitro diagnostic

    09/27/2021CODX
    Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28

    Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be introducing its upcoming at-home and point-of-care PCR device in a press conference at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, held September 26-30 in Atlanta, GA, as well as hosting a booth to promote its existing suite of diagnostics products and technology applications.

    09/23/2021CODX
    Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion

    Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that following its recent transformative growth, the Company is rebranding its image to better reflect its expanded scope, mission, and upcoming expansion into new diagnostics verticals.

    09/21/2021CODX
    Co-Diagnostics, Inc. to Present at ACTC Liquid Biopsy Conference in Kalamata, Greece

    Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Company representatives will be presenting at the 5th Advances in Circulating Tumor Cells (ACTC) conference in Kalamata, Greece, held on September 22-25, 2021.

    09/21/2021CODX
    Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico

    Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ Influenza A/Influenza B/COVID-19 "ABC" Test has been approved for sale in Mexico by the Mexican Department of Epidemiology ("InDRE") after InDRE successfully concluded an independent evaluation of the test's sensitivity and specificity for use as an RT-PCR multiplex test in that market.

    09/21/2021CODX
    Sidoti Fall Virtual Small Cap Investor Conference

    Presentation Times and Weblinks Released for Over 130 Presenting CompaniesWednesday and Thursday, September 22 - 23, 2021NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for its Sidoti Fall Virtual Small Cap Investor Conference, to be held on Wednesday, September 22, 2021, and Thursday, September 23, 2021. Virtual Agenda - Wednesday, September 22nd - All Times EDT Click on Company Name to Open Link to

    09/20/2021CODX
    Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference

    Co-Diagnostics, Inc. (NASDAQ: CODX) a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Dwight Egan, CEO, Brian Brown, CFO, and Andrew Benson, Head of Investor Relations, will present and host one-on-one meetings with investors at the Sidoti Fall Virtual Investor Conference.